Newsgroups Main » Newsgroups Directory » Science and Technology » Medicine
Cancer ( sci.med.diseases.cancer )
From [email protected] Wed Aug 31 12:48:42 1994 Path: uunet!bounce-back From: [email protected] (Arthur D. Flatau) Newsgroups: news.announce.newgroups,news.groups,alt.support.cancer,sci.med,sci.med.nutrition,sci.med.nursing,sci.med.physics,sci.med.radiology,sci.med.pharmacy Subject: RFD: sci.med.diseases.cancer Followup-To: news.groups Date: 30 Aug 1994 15:17:48 -0400 Organization: Computational Logic, Inc., Austin, TX 78703, U.S.A Lines: 68 Sender: [email protected] Approved: [email protected] Message-ID: <[email protected]> NNTP-Posting-Host: rodan.uu.net Xref: uunet news.announce.newgroups:5550 news.groups:114437 alt.support.cancer:1944 sci.med:98063 sci.med.nutrition:13378 sci.med.nursing:1697 sci.med.physics:2591 sci.med.radiology:607 sci.med.pharmacy:3670 REQUEST FOR DISCUSSION Group Name: sci.med.diseases.cancer Status: unmoderated Distribution: world Summary: discussion on all topics related to diagnosis and treatment of cancer Proposed by: Arthur Flatau ([email protected]) Cross Posted to: news.announce.newgroups, news.groups, alt.support.cancer, sci.med, sci.med.nutrition, sci.med.nursing, sci.med.physics, sci.med.radiology, sci.med.pharmacy This is a formal Request for Discussion (RFD) on the creation of a unmoderated newsgroup, sci.med.diseases.cancer. This RFD will also be mailed to the CANCER-L, breast-cancer and bmt-talk mailing lists. All discussion will take place on news.groups. It was suggested in consultation with the group-advice mailing list to create a new diseases hierarchy under sci.med for medical discussions of specific diseases. CHARTER The purpose of sci.med.diseases.cancer is discussions of the treatment and diagnosis of all forms of cancer. Sci.med.diseases.cancer is a forum for cancer patients, their families and loved ones, medical professionals and cancer researchers. Discussions of unconventional therapies are explicitly allowed, however claims made of unconventional therapy should substantiated with references to at least the popular press if not scientific literature. Unconventional therapy should be held to the same scientific standard as conventional therapy. The group will not be moderated. Appropriate topics include: * Diagnosis of cancer * Treatment of cancer, including surgery, chemotherapy, radiation, and immunotherapy * Screening and detection of cancer. * Prevention of cancer * Nutritional aspects of cancer treatment and prevention * Causes of cancer * Experimental treatments * Psychosocial aspects of cancer RATIONALE There are existing groups were the diagnosis and treatment of cancer is discussed (sci.med and alt.support.cancer). alt.support.cancer suffers from the usual drawbacks of groups in the alt hierarchy, including not being distributed as widely. There is no place specifically devoted to discussions on the medical aspects of cancer. Sci.med.diseases.cancer is intended to focus on technical aspects of treating cancer; emotional support is a better topic for alt.support.cancer or the above mailing lists (the distinction between what is technical and what is emotional will at times be blurry). From [email protected] Thu Oct 6 09:56:58 1994 Path: uunet!bounce-back From: [email protected] (Andrew Solovay) Newsgroups: news.announce.newgroups,news.groups,alt.support.cancer,sci.med,sci.med.nursing,sci.med.nutrition,sci.med.pharmacy,sci.med.physics,sci.med.radiology Subject: CFV: sci.med.diseases.cancer Followup-To: poster Date: 5 Oct 1994 23:30:46 -0400 Organization: Usenet Volunteer Votetakers (UVV) Lines: 112 Sender: [email protected] Approved: [email protected] Expires: 28 Oct 1994 00:00:00 GMT Message-ID: <[email protected]> References: <[email protected]> Reply-To: [email protected] (Andrew Solovay's vote-taking alias) NNTP-Posting-Host: rodan.uu.net Xref: uunet news.announce.newgroups:5741 news.groups:119220 alt.support.cancer:2381 sci.med:102240 sci.med.nursing:1960 sci.med.nutrition:14938 sci.med.pharmacy:4263 sci.med.physics:2685 sci.med.radiology:763 FIRST CALL FOR VOTES (of 2) unmoderated group sci.med.diseases.cancer Newsgroups line: sci.med.diseases.cancer Diagnosis, treatment, and prevention of cancer. Votes must be received by 23:59:59 GMT, 27 October 1994. This vote is being conducted by a neutral third party. For voting questions only contact [email protected] For questions about the proposed group contact Arthur Flatau <[email protected]>. The vote-taker will post each CFV to the following mailing lists shortly after it is posted to news.announce.newsgroups: CANCER-L <[email protected] breast-cancer <[email protected]> bmt-talk <[email protected]> He will send an abridged copy of the RESULT posting (without the full list of voters) to each of these mailing list after voting ends; the full RESULTs will be posted to all the newsgroups where the CFV was posted. CHARTER The purpose of sci.med.diseases.cancer is discussions of the treatment and diagnosis of all forms of cancer. Sci.med.diseases.cancer is a forum for cancer patients, their families and loved ones, medical professionals and cancer researchers. Discussions of unconventional therapies are explicitly allowed, however claims made of unconventional therapy should substantiated with references to at least the popular press if not scientific literature. Unconventional therapy should be held to the same scientific standard as conventional therapy. The group will not be moderated. Appropriate topics include: * Diagnosis of cancer * Treatment of cancer, including surgery, chemotherapy, radiation, and immunotherapy * Screening and detection of cancer. * Prevention of cancer * Nutritional aspects of cancer treatment and prevention * Causes of cancer * Experimental treatments * Psychosocial aspects of cancer RATIONALE There are existing groups were the diagnosis and treatment of cancer is discussed (sci.med and alt.support.cancer). alt.support.cancer suffers from the usual drawbacks of groups in the alt hierarchy, including not being distributed as widely. There is no place specifically devoted to discussions on the medical aspects of cancer. Sci.med.diseases.cancer is intended to focus on technical aspects of treating cancer; emotional support is a better topic for alt.support.cancer or the above mailing lists (the distinction between what is technical and what is emotional will at times be blurry). HOW TO VOTE Erase everything above the top "-=-=-=-" line and erase everything below the bottom "-=-=-=-" line. Do not erase anything between these lines and do not change the group name. Give your name on the line that asks for it. Place the word YES or NO between the brackets before the group name. Don't worry about spacing of the columns or any quote characters (">") that your reply inserts. Then mail the ballot to: [email protected] Just "Replying" to this message should work, but double-check the address before sending. If your vote isn't sent to <[email protected]>, it won't be counted. -=-=-=-=-=- Don't Delete Anything Between These Lines =-=-=-=-=-=-=-=- sci.med.diseases.cancer Ballot(Don't remove this marker) Give your real name here: Write "YES" or "NO" between the brackets: ----------------------------------------------------------------------- [ ] sci.med.diseases.cancer -=-=-=-=-=- Don't Delete Anything Between These Lines =-=-=-=-=-=-=-=- Anything else may be rejected by the automatic vote counting program. The votetaker will respond to your received ballots with a personal acknowledge- ment by mail - if you do not receive one within several days, try again. It's your responsibility to make sure your vote is registered correctly. Each person may vote only once, no matter how many accounts he or she may have. Also, only one ballot will be accepted from any account, no matter how many people may share it. If more than one vote is received >from any person or any account, only the last vote received will be counted. Addresses and votes of all voters will be published in the final voting results list. All ballots received are kept in the UVV archives (including "cancelled" and invalid ballots). The vote files are made available to the moderator of news.announce.newgroups on request. They may also, at the discretion of the UVV, be made more widely available if there is a controversy concerning the vote. From [email protected] Thu Oct 20 17:06:35 1994 Path: uunet!not-for-mail From: [email protected] (Andrew Solovay) Newsgroups: news.announce.newgroups,news.groups,alt.support.cancer,sci.med,sci.med.nursing,sci.med.nutrition,sci.med.pharmacy,sci.med.physics,sci.med.radiology Subject: 2nd CFV: sci.med.diseases.cancer Supersedes: <[email protected]> Followup-To: poster Date: 20 Oct 1994 15:34:23 -0400 Organization: Usenet Volunteer Votetakers (UVV) Lines: 144 Sender: [email protected] Approved: [email protected] Expires: 28 Oct 1994 00:00:00 GMT Message-ID: <[email protected]> References: <[email protected]> <[email protected]> Reply-To: [email protected] (Andrew Solovay's vote-taking alias) NNTP-Posting-Host: ten.uu.net Xref: uunet news.announce.newgroups:5816 news.groups:121183 alt.support.cancer:2537 sci.med:104086 sci.med.nursing:2084 sci.med.nutrition:15394 sci.med.pharmacy:4551 sci.med.physics:2722 sci.med.radiology:836 LAST CALL FOR VOTES (of 2) unmoderated group sci.med.diseases.cancer Newsgroups line: sci.med.diseases.cancer Diagnosis, treatment, and prevention of cancer. Votes must be received by 23:59:59 GMT, 27 October 1994. This vote is being conducted by a neutral third party. For voting questions only contact [email protected] For questions about the proposed group contact Arthur Flatau <[email protected]>. The vote-taker will post each CFV to the following mailing lists shortly after it is posted to news.announce.newsgroups: CANCER-L <[email protected]> breast-cancer <[email protected]> bmt-talk <[email protected]> He will send an abridged copy of the RESULT posting (without the full list of voters) to each of these mailing list after voting ends; the full RESULTs will be posted to all the newsgroups where the CFV was posted. CHARTER The purpose of sci.med.diseases.cancer is discussions of the treatment and diagnosis of all forms of cancer. Sci.med.diseases.cancer is a forum for cancer patients, their families and loved ones, medical professionals and cancer researchers. Discussions of unconventional therapies are explicitly allowed, however claims made of unconventional therapy should substantiated with references to at least the popular press if not scientific literature. Unconventional therapy should be held to the same scientific standard as conventional therapy. The group will not be moderated. Appropriate topics include: * Diagnosis of cancer * Treatment of cancer, including surgery, chemotherapy, radiation, and immunotherapy * Screening and detection of cancer. * Prevention of cancer * Nutritional aspects of cancer treatment and prevention * Causes of cancer * Experimental treatments * Psychosocial aspects of cancer RATIONALE There are existing groups were the diagnosis and treatment of cancer is discussed (sci.med and alt.support.cancer). alt.support.cancer suffers from the usual drawbacks of groups in the alt hierarchy, including not being distributed as widely. There is no place specifically devoted to discussions on the medical aspects of cancer. Sci.med.diseases.cancer is intended to focus on technical aspects of treating cancer; emotional support is a better topic for alt.support.cancer or the above mailing lists (the distinction between what is technical and what is emotional will at times be blurry). HOW TO VOTE Erase everything above the top "-=-=-=-" line and erase everything below the bottom "-=-=-=-" line. Do not erase anything between these lines and do not change the group name. Give your name on the line that asks for it. Place the word YES or NO between the brackets before the group name. Don't worry about spacing of the columns or any quote characters (">") that your reply inserts. Then mail the ballot to: [email protected] Just "Replying" to this message should work, but double-check the address before sending. If your vote isn't sent to <[email protected]>, it won't be counted. -=-=-=-=-=- Don't Delete Anything Between These Lines =-=-=-=-=-=-=-=- sci.med.diseases.cancer Ballot (Don't remove this marker) Give your real name here: Write "YES" or "NO" between the brackets: ----------------------------------------------------------------------- [ ] sci.med.diseases.cancer -=-=-=-=-=- Don't Delete Anything Between These Lines =-=-=-=-=-=-=-=- Anything else may be rejected by the automatic vote counting program. The votetaker will respond to your received ballots with a personal acknowledge- ment by mail - if you do not receive one within several days, try again. It's your responsibility to make sure your vote is registered correctly. Each person may vote only once, no matter how many accounts he or she may have. Also, only one ballot will be accepted from any account, no matter how many people may share it. If more than one vote is received >from any person or any account, only the last vote received will be counted. Addresses and votes of all voters will be published in the final voting results list. All ballots received are kept in the UVV archives (including "cancelled" and invalid ballots). The vote files are made available to the moderator of news.announce.newgroups on request. They may also, at the discretion of the UVV, be made more widely available if there is a controversy concerning the vote. INVALID VOTES ============= The following people have submitted invalid ballots, and have not superseded them with valid ones. If you are listed here, you must submit a proper ballot or your vote will not be counted. Votes in error ------------------------------------------------------------------------------ [email protected] Dave Filippi ! No ballot [email protected] ! No ballot [email protected] ! No vote statement in message [email protected] KATHY GORNY ! No vote statement in message zeinejohnsonds%[email protected] Satin ! No ballot BOUNCES ======= The following people have submitted valid votes to the voting address, but my EMail acknowledgement letter to them bounced. They do not need to revote. sci.med.diseases.cancer Bounce List ------------------------------------------------------------------------------ MARTINEZ.GEORGINA_V"@miami.va.gov [email protected] Paul J. Ste. Marie From [email protected] Tue Nov 1 18:34:00 1994 Path: uunet!bounce-back From: [email protected] (Andrew Solovay) Newsgroups: news.announce.newgroups,news.groups,alt.support.cancer,sci.med,sci.med.nursing,sci.med.nutrition,sci.med.pharmacy,sci.med.physics,sci.med.radiology Subject: RESULT: sci.med.diseases.cancer passes 210:11 Supersedes: <[email protected]> Followup-To: news.groups Date: 1 Nov 1994 17:58:20 -0500 Organization: Usenet Volunteer Votetakers (UVV) Lines: 301 Sender: [email protected] Approved: [email protected] Message-ID: <[email protected]> References: <[email protected]> <[email protected]> <[email protected]> NNTP-Posting-Host: rodan.uu.net Xref: uunet news.announce.newgroups:5878 news.groups:122140 alt.support.cancer:2703 sci.med:105368 sci.med.nursing:2204 sci.med.nutrition:15915 sci.med.pharmacy:4747 sci.med.physics:2764 sci.med.radiology:916 RESULT unmoderated group sci.med.diseases.cancer passes 210:11 There were 210 YES votes and 11 NO votes, for a total of 221 valid votes. There was 1 abstain and 8 invalid ballots. For group passage, YES votes must be at least 2/3 of all valid (YES and NO) votes. There also must be at least 100 more YES votes than NO votes. There is a five day discussion period after these results are posted. If no serious allegations of voting irregularities are raised, the moderator of news.announce.newgroups will create the group shortly thereafter. Voting closed at 23:59:59 GMT, 27 October 1994. This vote was conducted by a neutral third party. Vote-taker's address: [email protected] (Andrew Solovay) Group proponent's address: [email protected] (Arthur Flatau) Newsgroups line: sci.med.diseases.cancer Diagnosis, treatment, and prevention of cancer. CHARTER (culled from the Call for Votes) The purpose of sci.med.diseases.cancer is discussions of the treatment and diagnosis of all forms of cancer. Sci.med.diseases.cancer is a forum for cancer patients, their families and loved ones, medical professionals and cancer researchers. Discussions of unconventional therapies are explicitly allowed, however claims made of unconventional therapy should substantiated with references to at least the popular press if not scientific literature. Unconventional therapy should be held to the same scientific standard as conventional therapy. The group will not be moderated. Appropriate topics include: * Diagnosis of cancer * Treatment of cancer, including surgery, chemotherapy, radiation, and immunotherapy * Screening and detection of cancer. * Prevention of cancer * Nutritional aspects of cancer treatment and prevention * Causes of cancer * Experimental treatments * Psychosocial aspects of cancer sci.med.diseases.cancer Final Vote List Voted Yes ------------------------------------------------------------------------------ [email protected] Al Aqualino [email protected] Don McCallum [email protected] Hema Abeygunawardena [email protected] Ann B. Janak [email protected] Fran Adams [email protected] Amy Finley [email protected] Homayoon Akhiani [email protected] Judith M. Amory [email protected] audrey musil [email protected] Anselm Buehling [email protected] Jim Ault [email protected] Stephen T. Yavorsky [email protected] Bart Schraa [email protected] Frank Bartel [email protected] Corinne Bartow [email protected] Richard J. Conn [email protected] Ron Bauerle [email protected] Lora Kirk [email protected] Bengt Larsson [email protected] Bette Olson [email protected] Brian Fitzpatrick BGC%[email protected] Brad Curtis [email protected] Bill Hudgins [email protected] Anthony E. Bible [email protected] Bill Schoonover Jr [email protected] Dan Birchall [email protected] Bonnie Irwin [email protected] B.J. Herbison [email protected] Barbara Krumsee [email protected] Robert Marks [email protected] Barbara O'Keeffe [email protected] Frank Bonnet [email protected] Arlene Bronstein [email protected] Debbie [email protected] E. Loren Buhle, Jr. Ph.D. [email protected] SFC Gary Butler, Chief Compute [email protected] Camilla Cracchiolo [email protected] Volker Schulz [email protected] Eric C. Carlson [email protected] carol fitzpatrick [email protected] Mark Kupferman [email protected] YAU CHUN CHUNG [email protected] Chuck Beury [email protected] George Chang [email protected] Carl M. Lewis [email protected] Craig Poole [email protected] Cordah E. Robinson [email protected] Ceil Sinnex [email protected] Cheri Stine [email protected] Peter Campbell [email protected] Dale Smoak [email protected] Darragh J. Delany [email protected] David Linsey [email protected] Jeff Bowen [email protected] Delaine Sanders [email protected] Andy Delaney [email protected] David Gillespie [email protected] Dinesh Sharma [email protected] Douglas Bank [email protected] Bridget Doyle [email protected] Duane Day [email protected] Doug Eastick [email protected] Edwin Chong [email protected] Emily J. Gertz [email protected] Allan B. Elkowitz [email protected] Ellen Keyne Seebacher [email protected] Michael Dotzauer [email protected] elizabeth schoenfeld [email protected] Ellen S. Frank [email protected] William Affleck-Asch [email protected] Arthur D. Flatau [email protected] Sean P. Ryan [email protected] Gary Huckabay [email protected] Gary Goozee [email protected] W. Gregg Devanna, M.S. [email protected] Helga Gebauer [email protected] Dr. Julia MW Gee [email protected] G. Eric Roudabush [email protected] George Hasty [email protected] Rhett V. Pascual [email protected] Charlene Grall [email protected] Stephan Heilmayr [email protected] Henning Holtschneider [email protected] Henri Neethling [email protected] Helena T. Robinson [email protected] Ian H. Wendt [email protected] Jack Poulter [email protected] John A. Hipp [email protected] Jane Will [email protected] J.D. Almand DOAS Telcom [email protected] John W. Dye Jr. [email protected] John Freitas [email protected] Joseph M. Godsil ([email protected]) [email protected] James Thomas Green [email protected] Joyce Morris [email protected] Jim Macey [email protected] John Goddard [email protected] John Pimentel [email protected] John R. MacWilliamson [email protected] John R. Spencer [email protected] Judith Kovetz [email protected] Justin Sullivan [email protected] Dave Hoffman [email protected] Kenji Rikitake [email protected] Ken Herting [email protected] Keyvan Keyhani [email protected] Jeff C. Kimbel [email protected] Henry King [email protected] Barb Kirkpatrick [email protected] Michael Barela ([email protected]) [email protected] Karen Kolling [email protected] George Koomullil [email protected] Ken Robinson [email protected] [email protected] Martin Schr"oder [email protected] Lachlan Cranswick [email protected] Laurel Simmons [email protected] Alan Gould [email protected] Mary Lievore [email protected] Lorraine [email protected] Larry Laufman [email protected] Lowell Moore [email protected] James Luhn [email protected] Margaret Davey [email protected] Max Turner [email protected] Matt Ammann [email protected] Jim Mansfield [email protected] Marianne Sedacki [email protected] MARTINEZ.GEORGINA_V"@miami.va.gov [email protected] Alayne McGregor [email protected] Mahyar Dadkhah [email protected] David S. Mellish > [email protected] Dr. Christian Riedel [email protected] Marcelo Halpern [email protected] barbara blount [email protected] Michael C. Kolios [email protected] Marshall Kragen [email protected] Marie Ominski [email protected] Muriel Fay Siadak [email protected] Michael Leahy [email protected] Jeffrey G. Nanis [email protected] Matti Narkia [email protected] Nancy Oster [email protected] phil reed [email protected] Paul W. Eldridge, Ph.D. [email protected] Pierre Uszynski [email protected] Sandra Pinkerton [email protected] Andreas Polzer [email protected] Michelle Mader [email protected] Paul J. Ste. Marie [email protected] Marcos Rubinstein [email protected] Marylyn Westervelt [email protected] Rebecca Drayer [email protected] Ralph Cherubini [email protected] Richard J. Crilly [email protected] Edwin M. Read [email protected] Stefan Reuschke [email protected] Robert C. Hackman [email protected] Ron Hall [email protected] Richard Hong [email protected] Richard Miller [email protected] Richard Lavine [email protected] Robert N. Schlaug [email protected] Frank Roberson [email protected] Carl Hemenway [email protected] J. Rufinus [email protected] Ruddy Verbinnen [email protected] Sandy Mitchell [email protected] Stephanie Byram [email protected] Stephanie Bradley-Swift [email protected] William F. Schneider [email protected] Scott McElfresh [email protected] Michael J. Scudder [email protected] Sharon E. Snyder [email protected] High Octane Fuel [email protected] John H. McDonald [email protected] Sten Drescher [email protected] Sharyn L. Morris [email protected] Stephen Dunn [email protected] Stan Borkowski, MD [email protected] Sarah Skovronsky [email protected] Lawrence R. Stark [email protected] Stephan Blaschke [email protected] Eric Sandrich [email protected] Susan Whelan [email protected] Steve Kirchoefer [email protected] Gary W. Takahashi, M.D. [email protected] T F Lee [email protected] Thomas G. McWilliams [email protected] Thomas J. Remington [email protected] Tige L. Phillips [email protected] Ted O'Neill [email protected] Pauline L. V. MacDonald [email protected] Todd Cocks [email protected] Terri Damon [email protected] Toh, Hong Jin [email protected] Thomas Meixner [email protected] Timo Salmi [email protected] Rosemary Shannon [email protected] David Zatz [email protected] Victoria Yturralde [email protected] Wally Garchow [email protected] Lloyd Wheeler [email protected] William L. Dye [email protected] Craig Wyllie [email protected] Dave Shariff Yadallee [email protected] Jerry Young [email protected] Norma Wiley [email protected] zara haimo Voted No ------------------------------------------------------------------------------ [email protected] Ed Bailey [email protected] Brian Rowell [email protected] K.P. Crouch [email protected] Christopher Ward [email protected] Dodie O'Bryan [email protected] Emery Lapinski [email protected] John Lacey [email protected] Hasnain Khan [email protected] Sean Buckley [email protected] Dwight Brown [email protected] Stu Labovitz Abstained ------------------------------------------------------------------------------ [email protected] M Mike Taksar Votes in error ------------------------------------------------------------------------------ [email protected] Dave Filippi ! No ballot [email protected] James D. Almand ! Invalid address [email protected] Sara C. Wasson ! No ballot [email protected] ! No ballot [email protected] ! No vote statement in message [email protected] KATHY GORNY ! No vote statement in message [email protected] Mahesh Varia ! No vote statement in message zeinejohnsonds%[email protected] Satin ! No ballot
USENET FACT: Flaming
Flaming is the hostile interaction between multiple Usenet users.